Here's why Rahul Shah is bullish on HDFC Bank

"So, obviously, Sun will be my top of the priority in the Nifty universe as well and I would also look at Lupin, the numbers were in line with what we were estimating. So, I think post Sun, Lupin would be my preferred bet," says Rahul Shah, MOSL.

What is your view on the pharma? I think more or less the earnings have been impressive. But is there any specific name that comes out as a clear winner within the pack?
Rahul Shah: So, if I look at the entire pharma as a basket, most of the numbers were in line with the street estimates and no major disappointments in that perspective sector. So, in that space, we have been bullish on Sun Pharma for quite some time and last quarter numbers, the guidance was a little bit down and post that the stock had corrected.
But I believe the entire play if I have to look at entire pharma pack, then I think Sun remains the top bet.

So, obviously, Sun will be my top of the priority in the Nifty universe as well and I would also look at Lupin, the numbers were in line with what we were estimating. So, I think post Sun, Lupin would be my preferred bet.



What else is looking good in the market, even if tactically?
Rahul Shah: So, two things, one is obviously all eyes on the private sector banks. I think HDFC, what we will see, maybe the MSCI flow which everybody is waiting for it. So, my sense is that is one stock. Obviously, the results were also in line with what street was estimating. That is a clear winner in last few days and I feel that the risk versus reward is quite favourable in that stock. So, I think HDFC is top of the mind. Second, I think if I look at it, various other names in PSU names as well.

So, PSU banks look very interesting. If I look at it, PSU banks have also underperformed in these last two months. So, my sense, PSU banks again remain the top bets.

So, I think these two, one as a sector PSU banks and HDFC Bank in largecaps is what we have been recommending.